The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer

VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice

(2019) Yifat Bar-Zakay Rosenfeld et al.   ONCOGENE

MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2

(2018) Ri-sheng Huang et al.   LIFE SCIENCES

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer

(2017) Sonja M. Kessler et al.   Oncotarget

IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1

(2017) Ning Dai et al.   eLife

Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma

(2016) Ahmad Barghash et al.   Oncotarget

Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61

(2016) Makoto Sano et al.   NEOPLASIA

Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway

(2015) Qingchun Mu et al.   CANCER BIOLOGY & THERAPY

Overexpression ofIGF2mRNA-Binding Protein 2 (IMP2/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival

(2015) A. Barghash et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype

(2015) S M Kessler et al.   Cell Death & Disease

Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis

(2013) Y. Zhang et al.   CANCER RESEARCH

Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

(2013) G. Zhang et al.   CLINICAL CANCER RESEARCH

The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC?

(2013) Yvette Simon et al.   GUT

Insulin-like growth factor II messenger RNA–binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm

(2013) Katsuya Morimatsu et al.   HUMAN PATHOLOGY

Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer

(2013) Tatjana Crnogorac-Jurcevic et al.   PLoS One

IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling

(2012) Sonja M. Kessler et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery

(2012) Gregory Sergeant et al.   BMC CANCER

Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

(2012) Jessica L. Bell et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells

(2012) M. Janiszewska et al.   GENES & DEVELOPMENT

DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

(2012) Geng Zhang et al.   PLoS One

Diagnostic Value of Immunohistochemical IMP3 Expression in Core Needle Biopsies of Pancreatic Ductal Adenocarcinoma

(2011) David Lukas Wachter et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

(2011) Kim J. Png et al.   NATURE

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival

(2010) David F Schaeffer et al.   BMC CANCER